Exact Mass: 259.0568584

Glucosamine 6-phosphate

Phosphoric acid mono-((2R,3S,4R,5R)-5-amino-2,3,4-trihydroxy-6-oxo-hexyl) ester

Glucosamine 6-phosphate (CAS: 3616-42-0) is normally produced in endothelial cells via de novo glucosamine synthesis by the enzyme fructose-6-phosphate amidotransferase and the modulation of this pathway by hyperglycemia and glutamine. Glutamine-fructose-6-phosphate amidotransferase (GFAT) catalyzes the first committed step in the pathway for biosynthesis of hexosamines in mammals.It is a member of the N-terminal nucleophile class of amidotransferases, GFAT transfers the amino group from the L-glutamine amide to D-fructose 6-phosphate, producing glutamic acid and glucosamine 6-phosphate. As glucosamine inhibits endothelial nitric oxide synthesis it has important implications for impaired endothelium-dependent relaxation and vascular dysfunction in diabetes mellitus (PMID:11270676, 11842094). Glucosamine 6-phosphate is normally produced in endothelial cells via the de novo glucosamine synthesis by the enzyme fructose-6-phosphate amidotransferase and the modulation of this pathway by hyperglycemia and glutamine. glutamine-fructose-6-phosphate amidotransferase (GFAT) catalyzes the first committed step in the pathway for biosynthesis of hexosamines in mammals. A member of the N-terminal nucleophile class of amidotransferases, GFAT transfers the amino group from the L-glutamine amide to D-fructose 6-phosphate, producing glutamic acid and glucosamine 6-phosphate. As glucosamine inhibits endothelial nitric oxide synthesis it has important implications for impaired endothelium-dependent relaxation and vascular dysfunction in diabetes mellitus. (PMID 11270676, 11842094) [HMDB] Acquisition and generation of the data is financially supported in part by CREST/JST. KEIO_ID G021; [MS2] KO008968 KEIO_ID G021

Glucosamine-1P

{[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phosphonic acid

Glucosamine-1P is a substrate of enzyme UDP-N-acetylglucosamine diphosphorylase [EC 2.7.7.23] (KEGG). [HMDB] Glucosamine-1P is a substrate of enzyme UDP-N-acetylglucosamine diphosphorylase [EC 2.7.7.23] (KEGG). KEIO_ID G065

Skimmianine

4,7,8-trimethoxy-furo(2,3-b)quinoline

Skimmianine is a furoquinoline alkaloid present mainly in the Rutaceae family, with antispastic, anti-inflammatory activities and antiplatelet aggregation effect. Skimmianine exhibits cytotoxicity against a variety of cancer cell lines and genotoxicity[1]. Skimmianine is a furoquinoline alkaloid present mainly in the Rutaceae family, with antispastic, anti-inflammatory activities and antiplatelet aggregation effect. Skimmianine exhibits cytotoxicity against a variety of cancer cell lines and genotoxicity[1].

N-Sulfo-D-glucosamine

N-[(2R,3R,4R,5S,6R)-2,4,5-Trihydroxy-6-(hydroxymethyl)oxan-3-yl]sulphamic acid

N-Sulfo-D-glucosamine is a structurally altered form of N-acetyl-D-glucosamine (a polysaccharide found in animal tissues) by heparan sulfate N-deacetylase /N-sulfotransferase enzymes. No human references found [HMDB]

scyllo-Inosamine 4-phosphate

1-Amino-1-deoxy-scyllo-inositol 4-phosphate; scyllo-Inosamine 4-phosphate

Proacacipetalin

3-Butenenitrile, 2-(beta-D-glucopyranosyloxy)-3-methyl-, (S)-

Kokusaginine

Furo(2,3-b)quinoline, 4,6,7-trimethoxy-

Maculosidine

Furo(2,3-b)quinoline, 4,6,8-trimethoxy-

Kanosamine 6-phosphate

Kanosamine 6-phosphate; D-Kanosamine 6-phosphate

Aminofructose 6-phosphate

{[(2R,3S,4S)-4-amino-3,5-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]methoxy}phosphonic acid

This compound belongs to the family of Pentose Phosphates. These are carbohydrate derivatives containing a pentose substituted by one or more phosphate groups.

Arminum

p-Nitrophenyl-O-ethyl ethylphosphonate

D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors D004791 - Enzyme Inhibitors Same as: D01591

Vinclozolin M2

N-(3,5-Dichlorophenyl)-2-hydroxy-2-methylbut-3-enimidate

Cloethocarb

2-(2-chloro-1-methoxyethoxy)phenyl N-methylcarbamate

C11H14ClNO4 (259.0611314)

Pyrazofurin

C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2170 - Orotidylate Decarboxylase Inhibitor D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors

Glucosamine 1-phosphate

alpha-D-Glucosamine 1-phosphate

A galactosamine phosphate that is D-galactosamine substituted at position 1 by a monophosphate group.

Skimmianine

InChI=1/C14H13NO4/c1-16-10-5-4-8-11(13(10)18-3)15-14-9(6-7-19-14)12(8)17-2/h4-7H,1-3H

Skimmianine is an organonitrogen heterocyclic compound, an organic heterotricyclic compound, an oxacycle and an alkaloid antibiotic. Skimmianine is a natural product found in Haplophyllum bucharicum, Haplophyllum cappadocicum, and other organisms with data available. Skimmianine is a furoquinoline alkaloid present mainly in the Rutaceae family, with antispastic, anti-inflammatory activities and antiplatelet aggregation effect. Skimmianine exhibits cytotoxicity against a variety of cancer cell lines and genotoxicity[1]. Skimmianine is a furoquinoline alkaloid present mainly in the Rutaceae family, with antispastic, anti-inflammatory activities and antiplatelet aggregation effect. Skimmianine exhibits cytotoxicity against a variety of cancer cell lines and genotoxicity[1].

Glucosamine 6-sulfate

{[(2R,3S,4R,5R,6R)-5-amino-3,4,6-trihydroxyoxan-2-yl]methoxy}sulfonic acid

Glucosamine 6-sulfate is a naturally occurring compound present in many of the bodys tissues, and belongs to a class of compounds known as glycosaminoglycans (GAGs). Glucosamine 6-sulfate is being used in the treatment of arthritis. Glucosamine for arthritis products is usually formulated as the hydrochloride salt or glucosamine sulfate and often combined with chondroitin sulphate. It is notable that while both the hydrochloride salt and glucosamine sulfate are used in pharmaceutical preparations, glucosamine sulfate is thought to have a higher biological activity due to the presence of the sulfate. It should also be noted that there is a large cost difference between the two salts, with the hydrochloride salt being significantly less expensive. (PMID: 15925239) [HMDB] Glucosamine 6-sulfate is a naturally occurring compound present in many of the bodys tissues, and belongs to a class of compounds known as glycosaminoglycans (GAGs). Glucosamine 6-sulfate is being used in the treatment of arthritis. Glucosamine for arthritis products is usually formulated as the hydrochloride salt or glucosamine sulfate and often combined with chondroitin sulphate. It is notable that while both the hydrochloride salt and glucosamine sulfate are used in pharmaceutical preparations, glucosamine sulfate is thought to have a higher biological activity due to the presence of the sulfate. It should also be noted that there is a large cost difference between the two salts, with the hydrochloride salt being significantly less expensive. (PMID: 15925239).

Osmaronin

(2E)-3-methyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-2-enenitrile

Osmaronin is found in cereals and cereal products. Osmaronin is a constituent of the leaves of Hordeum vulgare (barley). Constituent of the leaves of Hordeum vulgare (barley). Osmaronin is found in barley and cereals and cereal products.

Lenalidomide

3-(4-amino-1-oxo-2,3-dihydro-1H-isoindol-2-yl)piperidine-2,6-dione

Lenalidomide (initially known as CC-5013 and marketed as Revlimid by Celgene) is a derivative of thalidomide introduced in 2004. It was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted therapeutic modality, but has also shown efficacy in the hematological disorders known as the myelodysplastic syndromes. [Wikipedia] C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent > C157388 - Immunomodulatory Imide Drug L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D006133 - Growth Substances > D043924 - Angiogenesis Modulating Agents D000970 - Antineoplastic Agents > D020533 - Angiogenesis Inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D006133 - Growth Substances > D006131 - Growth Inhibitors D007155 - Immunologic Factors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Mizoribine

1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-hydroxy-1H-imidazole-4-carboxamide

Mizoribine belongs to the family of 1-Ribosyl-imidazolecarboxamides. These are organic compounds containing the imidazole ring linked to a ribose ring through a 1-2 bond. D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D000893 - Anti-Inflammatory Agents D000970 - Antineoplastic Agents D018501 - Antirheumatic Agents D004791 - Enzyme Inhibitors Mizoribine (NSC 289637), an imidazole nucleoside, inhibits HCV RNA replication with IC50 of approximately 100 μM for anti-HCV activity. Immunosuppressant[1]. Mizoribine, an IMPDH inhibitor, inhibits replication of SARS-CoV with IC50s of 3.5 μg/mL and 16 μg/mL for SARS-CoV Frankfurt-1 and SARS-CoV HKU39849, respectively[2]. Mizoribine (NSC 289637), an imidazole nucleoside, inhibits HCV RNA replication with IC50 of approximately 100 μM for anti-HCV activity. Immunosuppressant[1]. Mizoribine, an IMPDH inhibitor, inhibits replication of SARS-CoV with IC50s of 3.5 μg/mL and 16 μg/mL for SARS-CoV Frankfurt-1 and SARS-CoV HKU39849, respectively[2].

Fumarycarnitine

(3S)-3-{[(2E)-3-carboxyprop-2-enoyl]oxy}-4-(trimethylazaniumyl)butanoate

Fumarycarnitine is an acylcarnitine. More specifically, it is an fumaric acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Fumarycarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine fumarycarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews]. A human metabolite taken as a putative food compound of mammalian origin [HMDB]

Propylparaben sulfate

Propyl para-hydroxybenzoic acid sulphuric acid(1-)

C10H11O6S- (259.0276326)

1-(3-Carboxypropylcarbamoyl)-5-fluorouracil

4-[(5-fluoro-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-1-carbonyl)amino]butanoic acid

C9H10FN3O5 (259.0604462)

4-Nitrophenyl 2-propylmethylphosphonate

4-nitrophenyl propan-2-yl methylphosphonate

Arasc

4-amino-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidine-2-thione

BEMORADAN

7-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)-3,4-dihydro-2H-1,4-benzoxazin-3-one

C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor

D-Glucosamine-6-phosphate

[(5-amino-2,3,4-trihydroxy-6-oxohexyl)oxy]phosphonic acid

Glycerophosphoserine

2-amino-3-{[(2,3-dihydroxypropoxy)(hydroxy)phosphoryl]oxy}propanoic acid

5-(1H-Indol-3-ylmethyl)-3-methyl-2-thioxo-4-Imidazolidinone

4-[(1H-indol-3-yl)Methyl]-1-methyl-2-sulphanyl-4,5-dihydro-1H-imidazol-5-one

1-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-hydroxyimidazole-4-carboxamide

1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-hydroxy-1H-imidazole-4-carboxamide

Pyrazofurin

3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1H-pyrazole-5-carboxamide

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors

4-Amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxypyrimidin-2-one

4-amino-1-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-1,2-dihydropyrimidin-2-one

1-(6-Aminopurin-9-yl)-5-methylpyrimidine-2,4-dione

1-(6-amino-9H-purin-9-yl)-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione

C10H9N7O2 (259.0817694)

THIARABINE

4-amino-1-[3,4-dihydroxy-5-(hydroxymethyl)thiolan-2-yl]-1,2-dihydropyrimidin-2-one

Cyclohexanones

2-(ethylamino)-2-(thiophen-2-yl)cyclohexan-1-one hydrochloride

C12H18ClNOS (259.0797568)

Cyclohexanones, also known as cn-54521-2ci-634tiletamine hydrochloride or cl 399, is a member of the class of compounds known as aralkylamines. Aralkylamines are alkylamines in which the alkyl group is substituted at one carbon atom by an aromatic hydrocarbyl group. Cyclohexanones can be found in tea, which makes cyclohexanones a potential biomarker for the consumption of this food product. Cyclohexanones is the organic compound with the formula (CH2)5CO. The molecule consists of six-carbon cyclic molecule with a ketone functional group. This colorless oil has an odor reminiscent of that of acetone. Over time, samples of cyclohexanone assume a yellow color. Cyclohexanones is slightly soluble in water and miscible with common organic solvents. Billions of kilograms are produced annually, mainly as a precursor to nylon .

Hippuric acid sulfate

N-[2-oxo-2-(Sulphooxy)ethyl]benzenecarboximidic acid

Rhodiocyanoside A

A cyanogenic glycoside that is (2Z)-2-methylbut-2-enenitrile attached to a beta-D-glucopyranosyloxy at position 4. Isolated from Rhodiola quadrifida, it exhibits anti-allergic activity.

Isomaculosidine

Furo(2,3-b)quinolin-4(9H)-one, 6,8-dimethoxy-9-methyl-

Furo(2,3-b)quinolin-4(9H)-one, 6,8-dimethoxy-9-methyl- is a natural product found in Dictamnus albus and Dictamnus dasycarpus with data available.

Tamynine

Isoskimmianine

Megistoquinone I

Tecleine

2C-B

2,2-dichloro-N-(2,6-diethylphenyl)acetamide

C11H17NO2S2 (259.07006620000004)

Maybridge3_002608

Maybridge3_002357

Maybridge1_004762

C9H10ClN3O2S (259.01822300000003)

Maybridge4_000930

2-Thiocytidin

N-hydroxycytidine

Pyrazomycin

(-)-alternarlactam|(1S)-6-hydroxy-8-methoxy-1-methyl-1H-cyclopenta[c]isoquinoline-3,5(2H,4H)-dione

C11H17NO2S2 (259.07006620000004)

Lissoclinotoxin C

D-glucosamine-6-phosphate

Pyrenoline B

4,5,6-Trimethoxyfurl[2,3-b]quinoline|4,5,6-trimethoxyfuroquinoline

SCHEMBL22219423

2-(beta-D-glucopyranosyloxy)-3-methyl-but-2-enenitrile|2-beta-D-Glucopyranosyloxy-3-methyl-crotononitril|2-beta-D-glucopyranosyloxy-3-methyl-crotononitrile|Acacipetalin

4,5,7-trimethoxyfuroquinoline|4,5,7-Trimethoxyfuro[2,3-b]quinoline

Caerulomycin I

A pyridine alkaloid that is 2,2-bipyridine-6-carboxamide substituted by methoxy groups at position 4 and carbamoyl nitrogen respectively. Isolated from the marine-derived actinomycete Actinoalloteichus cyanogriseus, it exhibits antineoplastic activity.

Cassiarin G

(6E)-3,4-dimethoxy-6-(nitrosomethylidene)-2-pyridin-2-yl-1H-pyridine

5,7-dimethoxy-9-methyl-4,9-dihydrofuro-[2,3-b]-chinolin-4-on|5,7-dimethoxy-9-methyl-9H-furo[2,3-b]quinolin-4-one|Glycarpin|Glycarpine

S-(2-Carboxy-1-(1H-imidazol-4-yl) ethyl)cysteine

(E)-2-(hydroxymethylene)butanenitrile beta-D-glucopyranoside|supinanitriloside F

(Z)-2-(beta-D-glucopyranosyloxy)but-2-enenitrile

DTXSID90840538

(2Z)-4-(beta-D-glucopyranosyloxy)-2-butenenitrile|4-beta-D-pyranoglucosyloxyl-2(Z)-propene-1-nitrile|alliarinoside

3-(4-chloro-phenyl)-2-methyl-3,7-dihydro-pyrrolo[2,3-d]pyrimidin-4-one

AG-370

3-amino-4-(1H-indol-5-ylmethylene)-2-pentenetricarbonitrile

C15H9N5 (259.0857914)

Skimmianine

Origin: Plant; SubCategory_DNP: Alkaloids derived from anthranilic acid, Quinoline alkaloids relative retention time with respect to 9-anthracene Carboxylic Acid is 1.053 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.048 Skimmianine is a furoquinoline alkaloid present mainly in the Rutaceae family, with antispastic, anti-inflammatory activities and antiplatelet aggregation effect. Skimmianine exhibits cytotoxicity against a variety of cancer cell lines and genotoxicity[1]. Skimmianine is a furoquinoline alkaloid present mainly in the Rutaceae family, with antispastic, anti-inflammatory activities and antiplatelet aggregation effect. Skimmianine exhibits cytotoxicity against a variety of cancer cell lines and genotoxicity[1].

Lenalidomide

C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent > C157388 - Immunomodulatory Imide Drug L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D006133 - Growth Substances > D043924 - Angiogenesis Modulating Agents D000970 - Antineoplastic Agents > D020533 - Angiogenesis Inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D006133 - Growth Substances > D006131 - Growth Inhibitors D007155 - Immunologic Factors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

D-GLUCOSAMINE 6-SULFATE

D-glucosamine 6-phosphate

C6H14NO8P (259.0457014)

D-Glucosamine-6-phosphate sodium salt

2-amino-2-deoxy-D-glucopyranose 6-phosphate

C14H13NO4_4,7,8-Trimethoxyfuro[2,3-b]quinoline

NCGC00016333-05_C14H13NO4_4,7,8-Trimethoxyfuro[2,3-b]quinoline

Glucosamine 6-sulfate

D-Glucosamine-6-sulfate

Glucosamine 6-phosphate

2-Thiocytidine

4-Amino-1-pentofuranosyl-2(1H)-pyrimidinethione

2-Thiocytidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

alpha-Galactosamine-1-phosphate

Glucosamine-6-phosphate

(Z)-2-methyl-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybut-2-enenitrile

4-Bromo-2,5-dimethoxyphenethylamine

D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists

GLUCOSE 6-PHOSPHORATE

skimmianine_major

skimmianine_61.3\\%

(Z)-2-methyl-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybut-2-enenitrile_major

1-METHYL-6,7-DIHYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINE HYDROBROMIDE

6,7-Isoquinolinediol,1,2,3,4-tetrahydro-1-methyl-, hydrobromide (1:1)

1-METHYL-6,7-DIHYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINE

6,7-Isoquinolinediol,1,2,3,4-tetrahydro-1-methyl-, hydrobromide (1:1)

mizoribine

D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D000893 - Anti-Inflammatory Agents D000970 - Antineoplastic Agents D018501 - Antirheumatic Agents D004791 - Enzyme Inhibitors Mizoribine (NSC 289637), an imidazole nucleoside, inhibits HCV RNA replication with IC50 of approximately 100 μM for anti-HCV activity. Immunosuppressant[1]. Mizoribine, an IMPDH inhibitor, inhibits replication of SARS-CoV with IC50s of 3.5 μg/mL and 16 μg/mL for SARS-CoV Frankfurt-1 and SARS-CoV HKU39849, respectively[2]. Mizoribine (NSC 289637), an imidazole nucleoside, inhibits HCV RNA replication with IC50 of approximately 100 μM for anti-HCV activity. Immunosuppressant[1]. Mizoribine, an IMPDH inhibitor, inhibits replication of SARS-CoV with IC50s of 3.5 μg/mL and 16 μg/mL for SARS-CoV Frankfurt-1 and SARS-CoV HKU39849, respectively[2].

Glucosamine-1P

Osmaronin

(2E)-3-methyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}but-2-enenitrile

Fumarycarnitine

(3S)-3-{[(2E)-3-carboxyprop-2-enoyl]oxy}-4-(trimethylazaniumyl)butanoate

N-BENZYL-2-CHLORO-9H-PURIN-6-AMINE

C12H10ClN5 (259.062469)

1-methoxy-3-nitro-2-phenylmethoxybenzene

(s)-3-amino-2-oxetanone p-toluenesulfonic acid salt

4-[(1-oxo-3,4-dihydronaphthalen-2-ylidene)methyl]benzonitrile

C18H13NO (259.09970880000003)

5-chloro-4-(dimethoxymethyl)-2-(3-methoxypropyl)pyridine

C12H18ClNO3 (259.0975148)

2-Hydroxy-3-nitro-[1,1-biphenyl]-3-carboxylic acid

2-(2,4-difluorophenyl)-5-(trifluoromethyl)pyridine

C12H6F5N (259.0420376)

4,4-Dinitro-2-biphenylamine

METHYL 2-METHOXY-4-[(METHYLSULFONYL)AMINO]-BENZOATE

6-(2,4-Dimethoxyphenyl)-nicotinic acid

Azetepa

Phosphinic amide,P,P-bis(1-aziridinyl)-N-ethyl-N-1,3,4-thiadiazol-2-yl-

C8H14N5OPS (259.0656644)

C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent

5-NITRO-2-(PHENYLTHIO)BENZALDEHYDE

C13H9NO3S (259.0303124)

1-(Dichloroacetyl)-1,2,3,4-tetrahydro-6-quinolinol

C13H19Cl2N (259.08944740000004)

1-Benzyl-4-chloromethylpiperidine hydrochloride

2,4-Pentanedione - cobalt (2:1)

C10H16CoO4 (259.0380516)

4-(2-AMINO-2-CARBOXYETHYL)BENZO[C]-2,1,3-THIADIAZOLE, HYDROCHLORIDE

C9H10ClN3O2S (259.01822300000003)

4-Phosphonomethyl-L-Phenylalanine

methyl (E)-4-anilino-5,5,5-trifluoropent-3-enoate

Phosphonic acid,P-(4-nitrophenyl)-, diethyl ester

1-ACETYLINDOLINE-5-SULFONYL CHLORIDE

4-CHLORO-2-(2-PYRIDINYL)-6-(TRIFLUOROMETHYL)-PYRIMIDINE

C10H5ClF3N3 (259.0124076)

4-(2-HYDROXY-PHENYL)-4,5,6,7-TETRAHYDRO-1H-IMIDAZO[4,5-C]PYRIDINE-6-CARBOXYLIC ACID

4-(4-Phenoxyphenyl)-3-thiosemicarbazide

Phosphomycin phenylethylamine

C11H18NO4P (259.0973398)

6-Benzyl-4-chloro-5,6,7,8-tetrahydropyrido[4,3-d]pyriMidine

6,7-DIHYDROXY-1-METHYL-1,2,3,4-TETRAHYDROISOQUINOLINE HYDROBROMIDE

2,3-Dihydro-α-(trifluoromethyl)-1H-indole-2-propanoic acid

3-[[[2-[(Aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]propanamide

C8H13N5OS2 (259.0561488)

2-dimethoxyphosphinothioylsulfanyl-N-(methoxymethyl)acetamide

C6H14NO4PS2 (259.0101854)

4-phosphonomethyl-d-phenylalanine

1-(4-nitrophenyl)-3-(2-thienyl)-prop-2-en-1-one

C13H9NO3S (259.0303124)

(+/-)-2-AMINO-6,7-DIHYDROXY-1,2,3,4-TETRAHYDRONAPHTHALENE HBR

C8H12F3NO5 (259.06675379999996)

eglinazine-ethyl

C9H14ClN5O2 (259.0835974)

2-(4-Aminophenyl)-1,1,1,3,3,3-hexafluoropropan-2-ol

C9H7F6NO (259.0431804)

2-amino-6-(trifluoromethyl)benzoic acid, trihydrate

2-MORPHOLINO-5-(TRIFLUOROMETHYL)BENZALDEHYDE

2-(2-BROMO-4,5-DIMETHOXYPHENYL)ETHANAMINE HYDROCHLORIDE

6-(3,4-DIMETHOXYPHENYL)NICOTINIC ACID

C11H5F4NO2 (259.02563979999996)

3-[2-fluoro-4-(trifluoromethyl)phenyl]pyrrole-2,5-dione

2-(1-(TERT-BUTOXYCARBONYL)AZETIDIN-3-YL)MALONIC ACID

1-(4-(BIS(2-CHLOROETHYL)AMINO)PHENYL)ETHANONE

N-(4-Methoxybenzyl)-4-nitropyridin-2-amine

ETHYL 2-(5-((ETHOXYCARBONYL)AMINO)-1,2,4-THIADIAZOL-3-YL)ACETATE

5-[(2-methyl-1-benzofuran-6-yl)methylidene]-1,3-thiazolidine-2,4-dione

C13H9NO3S (259.0303124)

Benzoic acid,4-(4-nitrophenoxy)-

4-(2-oxopyrrolidin-1-yl)benzenesulfonyl chloride

2-CBZ-AMINO-ETHANESULFONIC ACID

ciclobendazole

P - Antiparasitic products, insecticides and repellents > P02 - Anthelmintics > P02C - Antinematodal agents > P02CA - Benzimidazole derivatives C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent

2,3-Naphthalenediol,6-amino-5,6,7,8-tetrahydro-, hydrobromide (1:1)

4-CHLORO-4-HYDROXY-3-METHOXY-[1,1-BIPHENYL]-3-CARBONITRILE

2-(4-(METHYLSULFONYL)-2-NITROPHENYL)ACETIC ACID

PSI-6130

C10H14FN3O4 (259.0968296)

PSI-6130 is a potent and selective inhibitor of HCV NS5B polymerase, and inhibits HCV replication with a mean IC50 of 0.6 μM.?

N-(2,2-Dimethoxyethyl)-4-methylbenzenesulfonamide

4-(phosphonomethyl)-d,l-phenylalanine

N-Phthalyl-DL-glutamic Anhydride

1,4-Benzenediol,1-(4-nitrobenzoate)

N-tosyliminobenzyliodinane

C12H22BrN (259.09355120000004)

12-Bromododecanenitrile

4-(1-Pyrrolidinyl)-3-(trifluoromethyl)benzoic acid

2-(3-(3,4-Dichlorophenyl)pyrrolidin-3-yl)ethanol

nitrosalol

6-Methyl-2-(4-vinylphenyl)-1,3,6,2-dioxazaborocane-4,8-dione

1-Phenylvinylboronic acid MIDA ester

ETHYL 5-ACETYL-3-PHENYLISOXAZOLE-4-CARBOXYLATE

{3-[(2-Fluorophenyl)carbamoyl]phenyl}boronic acid

(4-(2-NITROPHENOXY)PHENYL)BORONIC ACID

(4-Fluoro-3-(phenylcarbamoyl)phenyl)boronic acid

ACRIFLAVINE

2-ISOPROPOXY-6-(2,2,2-TRIFLUOROETHOXY)BENZONITRILE

6-(4-Methoxybenzyloxy)pyridin-3-ylboronic acid

N-(2-CHLOROETHYL)-1,8-NAPHTHALIMIDE

C14H13NS2 (259.04893780000003)

2-(Ethylthio)phenothiazine

4-Methoxy-2-nitro-1-(phenylmethoxy)benzene

C10H14ClN3O3 (259.07236439999997)

5-Nitro-2-(3-piperidinyloxy)pyridine hydrochloride

2-chloro-7-methyl-3-(5-methyl-1,2,4-oxadiazol-3-yl)quinoline

(r)-alpha-(4-fluorobenzyl)-proline-hcl

(2S,4R)-4-(2-Fluorobenzyl)pyrrolidine-2-carboxylic acid hydrochloride

(2S,4R)-4-(4-Fluorobenzyl)pyrrolidine-2-carboxylic acid hydrochloride

(S)-2-(2-FLUOROBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE

(R)-2-(2-FLUOROBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE

(S)-2-(3-FLUOROBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE

(R)-3-Amino-2-oxetanone p-toluenesulfonic acid salt

4-chloro-6-(4-methoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidine

1-[4-(4-METHYL-4H-PYRAZIN-1-YL)-3-NITRO-PHENYL]-ETHANONE

4-chloro-7-methoxy-2-pyrazol-1-ylquinoline

(4-[(4-NITROBENZYL)OXY]PHENYL)METHANOL

(3-FLUORO-4-(PHENYLCARBAMOYL)PHENYL)BORONIC ACID

4-Amino-5-(ethylsulfonyl)-2-methoxybenzoic acid

4-Phenyl-5-(2-thienyl)-4H-1,2,4-triazol-3-ylhydrosulfide

C12H9N3S2 (259.0237874)

Fadrozole hydrochloride

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D047072 - Aromatase Inhibitors C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1740 - Aromatase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist D000970 - Antineoplastic Agents

1-(PHENYLSULFONYL)-1H-BENZOTRIAZOLE

C11H5F4NO2 (259.02563979999996)

1-PYRENEISOTHIOCYANATE

C17H9NS (259.0455674)

Methyl 2-amino-4-(2-chloroethoxy)-5-methoxybenzoate

C11H14ClNO4 (259.0611314)

6-fluoro-4-(trifluoromethyl)quinoline-2-carboxylic acid

5-CHLORO-2-(PHENYLTHIO)-INDOLE

C14H10ClNS (259.022245)

6-Chloro-3H-spiro[isobenzofuran-1,4-piperidine] hydrochloride

5-Chloro-3H-spiro[isobenzofuran-1,4-piperidine] hydrochloride

3-(2-OXOPYRROLIDIN-1-YL)BENZENE-1-SULFONYL CHLORIDE

Ethyl 7-(trifluoromethyl)imidazo[1,2-a]pyrimidine-6-carboxylate

C10H8F3N3O2 (259.0568584)

bis(2-nitrophenyl)amine

2-Fluoro-6-[4-(methylthio)phenoxy]benzonitrile

C14H10FNOS (259.0467102)

2-DIETHOXYMETHYL-THIAZOLE-4-CARBOXYLIC ACID ETHYL ESTER

cyprazole

C10H14ClN3OS (259.0546064)

N,N-DIMETHYLANILINE HYDROCHLORIDE

5-FLUORO-2-(4-METHOXYPHENYL)BENZO[D]THIAZOLE

C14H10FNOS (259.0467102)

4-oxo-4-[3-(trifluoromethyl)anilino]but-2-enoic acid

C11H8F3NO3 (259.0456254)

2-fluoro-7,8,9,10-tetrahydro-6h-cyclohepta[b]quinoline-11-carboxylic acid

1,3(2H)-PYRIDINEDICARBOXYLIC ACID, 3-METHYL 1-PHENYL ESTER

2,4-Dinitrodiphenylamine

URAMIL-N,N-DIACETIC ACID

C8H9N3O7 (259.0440484)

Morpholinium toluene-4-sulphonate

Benzenesulfonamide,N,N-bis(2-hydroxyethyl)-4-methyl-

Necrostatin-1

5-(1H-Indol-3-ylmethyl)-3-methyl-2-thioxo-4-Imidazolidinone

L-NIL dihydrochloride

L-N6-(1-Iminoethyl)lysine dihydrochloride

C8H19Cl2N3O2 (259.0854254)

cis-4-Phenylthio-L-proline hydrochloride

C11H14ClNO2S (259.0433734)

BENZOIC ACID, 2-HYDROXY-, 4-NITROPHENYL ESTER

phthaloyl-l-glutamic anhydride

(1S)-(-)-CAMPHANICACIDAMIDE

ETHYL5-CYANO-1-(3-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE

C13H10FN3O2 (259.0757012)

ETHYL5-CYANO-1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBOXYLATE

C13H10FN3O2 (259.0757012)

4-Chloro-2-(3-pyridinyl)-6-(trifluoromethyl)pyrimidine

C10H5ClF3N3 (259.0124076)

4-Chloro-N-(3,5-dimethylphenyl)benzamide

3a-(Trifluoromethyl)-3,3a-dihydrobenzo[d]pyrrolo[2,1-b]thiazol-1(2H)-one

C11H8F3NOS (259.0278674)

5-bromo-2-(diethoxymethyl)pyridine

(S)-(-)-3-Aminotetrahydrofuran-4-toluenesulfonate

C7H17NO7S (259.07256920000003)

azintamide

C10H14ClN3OS (259.0546064)

C78276 - Agent Affecting Digestive System or Metabolism > C66913 - Cholagogues or Choleretic Agents

TAPSO

(S)-Glycidyl nosylate

2-amino-1-[4-(2-hydroxy-ethyl)-piperazin-1-yl]-ethanone 2 hcl

C8H19Cl2N3O2 (259.0854254)

Magneson

4-(4-Nitrophenylazo)resorcinol

4-(4-nitrophenylazo)catechol

Benzenamine,4-[2-(3-chlorophenyl)diazenyl]-N,N-dimethyl-

3-(3-THIOPHEN-2-YL-PYRAZOLO[1,5-A]PYRIMIDIN-6-YL)-PROPAN-1-OL

C8H9N3O5S (259.02629040000005)

(Z)-2-(Methoxycarbonylmethoxyimino)-2-(2-aminothiazol-4-yl)acetic acid

(E)-3-(5-IODO-2-FURYL)PROP-2-ENOIC ACID

1-(1-ADAMANTYL)ETHYLAMINE

1-(5-Bromo-3-fluoropyridin-2-yl)piperazine

C9H11BrFN3 (259.0120318)

1-(2-(trimethylsilyl)ethoxycarbonyloxy)&

C10H17NO5Si (259.0875952)

N-(1,3-benzodioxol-5-ylmethyl)-1-(4-fluorophenyl)methanamine

(R)-(-)-Glycidyl nosylate

7-Benzyl-1-oxa-7-azaspiro[4.4]nonane-4,6,8-trione

2-(3-CHLOROPHENYL)-5-METHYLBENZO[D]THIAZOLE

C14H10ClNS (259.022245)

METHYL 3-AMINO-4,5-DIHYDRONAPHTHO[1,2-B]THIOPHENE-2-CARBOXYLATE

4-((1H-INDAZOL-4-YL)OXY)-3-CHLOROANILINE

C12H18FNO2S (259.10422200000005)

2,5-DIMETHOXY-4-(2-FLUORETHYLTHIO)-PHENYLETHYLAMIN

Oxalinast

2,2-[(3-bromophenyl)imino]bisethanol

2-[(2,5-DIMETHYL-FURAN-3-CARBONYL)-AMINO]-BENZOIC ACID

2-amino-5-methyl-4-(4-nitrophenyl)thiophene-3-carbonitrile

1-ETHYL-1-METHYLPYRROLIDINIUM HEXAFLUOROPHOSPHATE

C7H16F6NP (259.0924498)

5-Methyl-2-[(2-nitrophenyl)amino]thiophene-3-carbonitrile

4(1H)-Pyrimidinone,6-amino-5-(2,2-diethoxyethyl)-2,3-dihydro-2-thioxo-

C10H17N3O3S (259.0990572)

(S)-(+)-Glycidyl-4-nitrobenzoate

Benzoic acid,2-[[(4-fluorophenyl)amino]carbonyl]-

C14H10FNO3 (259.0644682)

3-(5-(2-nitrophenyl)furan-2-yl)acrylic

methyl 2-(5-amino-6-oxo-2-phenylpyrimidin-1-yl)acetate

2-Chloro-N-(3,4,5-trimethoxyphenyl)acetamide

C11H14ClNO4 (259.0611314)

2-(2,6-DICHLOROPHENOXY)-3-(DIMETHYLAMINO)ACRYLALDEHYDE

C9H14BNO5S (259.06857040000006)

(3-(N,N-dimethylsulfamoyl)-4-Methoxyphenyl)boronic acid

4-Chloro-1-isobutyl-1H-imidazo[4,5-c]quinoline

5-Aminouridine

1-Pyrrolidinecarboxylic acid, 4-(acetylthio)-2-(hydroxymethyl)-, 2-propen-1-yl ester, (2S,4S)

(S)-METHYL 2-AMINO-3-(4-HYDROXY-2,6-DIMETHYLPHENYL)PROPANOATE HYDROCHLORIDE

C12H18ClNO3 (259.0975148)

{3-[(3-Fluorophenyl)carbamoyl]phenyl}boronic acid

L-NIL hydrochloride

C8H19Cl2N3O2 (259.0854254)

(2-AMINO-4-(ISOPROPOXYCARBONYL)PHENYL)BORONIC ACID HYDROCHLORIDE

C10H15BClNO4 (259.078261)

Cyclopentanecarboxylicacid, 1-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-

C13H19Cl2N (259.08944740000004)

1-benzyl-3-(chloromethyl)piperidine

N-(4-Bromo-1-methyl-1H-pyrazol-5-yl)pivalamide

C9H14BrN3O (259.03201740000003)

Methyl morpholine-2-carboxylate 2,2,2-trifluoroacetate

C8H12F3NO5 (259.06675379999996)

(R)-2-(3-FLUOROBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE

C8H9N3O5S (259.02629040000005)

Methyl 6-methoxyformamido-4-chloropyridin-2-ylcarbamate

C9H10ClN3O4 (259.035981)

7-AMINO-1,8-NAPHTHYRIDIN-2(1H)-ONE SULFATE

2-(3-aminophenyl)-1,1,1,3,3,3-hexafluoropropan-2-ol

C9H7F6NO (259.0431804)

3-METHOXY-4-NITROPHENYL-BENZYL ETHER

5-(3,4-DIMETHOXYPHENYL)NICOTINIC ACID

2-Amino-5,6-dihydroxy-1,2,3,4-tetrahydronaphthalene hydrobromide

(4-chlorophenyl)(4-piperidyl)methanone hydrochloride

Benzaldehyde,4-[bis(2-chloroethyl)amino]-2-methyl-

2-(4-AMINO-2-CHLOROPHENYL)BENZO[D]OXAZOL-5-AMINE

{4-[(2-Fluorophenyl)carbamoyl]phenyl}boronic acid

Methyl 2-amino-4-(3-methoxyphenyl)pyrimidine-5-carboxylate

4-(2-Pyridylazo)resorcinol

C11H7N3Na2O2 (259.0333642)

4,4-dinitrodiphenylamine

4-(N,N-Dimethylsulfamoyloxy)benzamidoxime

(3-Chlorophenyl)(piperidin-4-yl)methanone

8-chloro-1-oxido-5,6-dihydrobenzo[1,2]cyclohepta[2,4-b]pyridin-1-ium-11-one

2-CHLORO-4-DIMETHYLAMINOAZOBENZENE

4-Amino-3-fluoropyridine

C13H19Cl2N (259.08944740000004)

1-Benzyl-4-(chloromethyl)piperidine hydrochloride

2-oxo-1,3,4,5-tetrahydro-1-benzazepine-7-sulfonyl chloride

C8H10ClN5O3 (259.04721400000005)

2-chloro-6-morpholin-4-yl-5-nitropyrimidin-4-amine

dimethylammonium 2-(4-chloro-2-methylphenoxy)propionate

C12H18ClNO3 (259.0975148)

2-(chloromethyl)-4-[(4-chlorophenyl)methyl]morpholine

4-[2-(pyrimidin-2-ylamino)ethoxy]benzoic acid

N-cyclohexyl-1-benzothiophene-2-carboxamide

C15H17NOS (259.1030792)

2-nitro-5-phenoxybenzoic acid

2-(3-Carbethoxy-4-hydroxypyrrolidin-2-on-1-yl)ethyl acetate

(2-FLUORO-5-(PHENYLCARBAMOYL)PHENYL)BORONIC ACID

{4-[(3-Fluorophenyl)carbamoyl]phenyl}boronic acid

4-(2-Chloroethoxy)-5-methoxy-2-nitrobenzaldehyde

C10H10ClNO5 (259.024748)

1H-1,2,4-Triazole-3-carboxylicacid, 1-β-D-ribofuranosyl-, methyl ester

2-(3-nitrophenoxy)Benzoic acid

N-(2-benzylphenyl)-2-chloroacetamide

5-chloro-3-phenylsulfanyl-1H-indole

C14H10ClNS (259.022245)

4-ETHOXY-1-NAPHTHOIC ACID

(S)-2-(4-FLUOROBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID HYDROCHLORIDE

Captopril EP Impurity J

N-(3,4-dichlorophenyl)hexanamide

(1H-benzoimidazol-2-yl)-(4-chloro-6-methyl-pyrimidin-2-yl)-amine

C12H10ClN5 (259.062469)

2,4-dinitrodiphenylamine

(S)-3-Aminotetrahydrofuran

N-Benzoylhistidine

Formamide,N-(2-benzoyl-4-chlorophenyl)-

CAPSO sodium salt

C9H18NNaO4S (259.0854188)

N-[2-(4-CHLORO-PHENYL)-ETHYL]-BENZAMIDE

Acriflavinium chloride

3,6-Diamino-10-methylacridinium chloride

C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent

5-(3,5-difluorobenzyl)-1H-indazol-3-ylamine

C14H11F2N3 (259.092099)

thenoyl methionate

C10H13NO3S2 (259.0336828)

(3S,4R)-4-(4-(TRIFLUOROMETHYL)PHENYL)PYRROLIDINE-3-CARBOXYLIC ACID

C12H13N5S (259.08916180000006)

3-(3-ETHYL-[1,2,4]TRIAZOLO[3,4-B][1,3,4]-THIADIAZOL-6-YL)-2-METHYL-PHENYLAMINE

6-Amino-5-azacytidine

C8H13N5O5 (259.0916648)

N-(2-Fluoro-5-Methylphenyl)-4-MethoxybenzaMide, 97\\%

N-(4-Chloro-phenyl)-guanidine oxalate

C9H10ClN3O4 (259.035981)

N-Benzyl-4-(chloroMethyl)benzaMide

N-(2-Fluoro-4-Methylphenyl)-4-MethoxybenzaMide, 97\\%

C8H12F3NO5 (259.06675379999996)

(4-Morpholinyl)acetic acid trifluoroacetic acid salt

ethyl 8-cyano-7-Methoxy-2-MethyliMidazo[1,2-a]pyridine-3-carboxylate

N-(3-aminopropyl)-2-nitrobenzenesulfonamide

4-(2,4-Dinitrobenzyl)pyridine

N-((4-methylphenyl)sulfonyl)serine

(3-(4-Nitrophenoxy)phenyl)boronic acid

(3-(2-Nitrophenoxy)phenyl)boronic acid

C12H18FNO2S (259.10422200000005)

4-Fluoro-N,N-diisopropylbenzenesulfonamide

methyl 5-chloroindeno[1,2-b]pyridine-5-carboxylate

2-(PHENYLTHIO)-PYRIDINE-4-CARBOXYLIC ACID ETHYL ESTER

N-[(4S,6S)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-4-yl]acetamide

C10H13NO3S2 (259.0336828)

aniline hydrogen phthalate

(4-[(3-METHYL-FURAN-2-CARBONYL)-AMINO]-PHENYL)-ACETIC ACID

2-(4-methoxy-benzenesulfonylamino)-propionic acid

N-(4-Methoxybenzyl) 4-fluorobenzamide

2-(4-nitrophenoxy)benzoic acid

trans-4-(2-(Trifluoromethyl)phenyl)pyrrolidine-3-carboxylic acid hydrochloride

4-CHLORO-4-DIMETHYLAMINOAZOBENZENE

2-(1,3-BENZODIOXOL-5-YLOXY)NICOTINIC ACID

1-(1H-imidazol-4-ylsulfonyl)piperidine-4-carboxylic acid

1-(1H-imidazol-4-ylsulfonyl)piperidine-3-carboxylic acid

(R)-3-Aminotetrahydrofuran Tosylate

(4-(4-NITROPHENOXY)PHENYL)BORONIC ACID

6-(3,4-DIMETHOXYPHENYL)PICOLINIC ACID

C9H6ClD4N5O2 (259.07740771199997)

imidacloprid d4 (imidazolidin-4,4,5,5 d4)

6-chloro-5-(3-methyl-2H-indazol-5-yl)pyridin-3-ol

Nicotinyl alcohol tartrate

Nicotinyl alcohol D-tartrate

C10H13NO7 (259.0691988)

C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

(3S,4R)-4-(2,5-dichlorophenyl)pyrrolidine-3-carboxylic acid

(3S,4R)-4-(2,3-dichlorophenyl)pyrrolidine-3-carboxylic acid

trans-2-Phenylvinylboronic acid MIDA ester

N-(5-Bromo-2-fluorobenzyl)-N-ethylethanamine

C11H15BrFN (259.0371822)

5,6-Bis(2-furyl)-3-methylthio-1,2,4-triazine

2-(2,4-Dinitrobenzyl)pyridine

[2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-4-yl]methanol

C11H8F3NOS (259.0278674)

Fosfomycin tromethamine

C7H18NO7P (259.0820848)

C254 - Anti-Infective Agent > C255 - Urinary Anti-Infective Agent D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents

trans-4-(3-(Trifluoromethyl)phenyl)pyrrolidine-3-carboxylic acid hydrochloride

{4-[(4-Fluorophenyl)carbamoyl]phenyl}boronic acid

{3-[(4-Fluorophenyl)carbamoyl]phenyl}boronic acid

9-chloro-10-nitro-9,10-dihydroanthracene

8-(MORPHOLIN-4-YL)-5-NITROQUINOLINE

4-[(4-fluorobenzoyl)amino]benzoic acid

C14H10FNO3 (259.0644682)

1H-indole-3-butanoic acid, alpha,gamma-dioxo-, ethyl ester

3-(4-NITROPHENOXY)BENZOICACID

3-Cyano-7-ethoxy-4-hydroxy-6-nitroquinoline

N-((4R,6S)-6-METHYL-7,7-DIOXIDO-5,6-DIHYDRO-4H-THIENO[2,3-B]THIOPYRAN-4-YL)ACETAMIDE

C10H13NO3S2 (259.0336828)

N-[(4-methoxyphenyl)sulfonyl]-D-alanine

beta-D-Glucosamine sulfate

(5-Amino-2,3,4-trihydroxy-6-oxohexyl) dihydrogen phosphate

N(4)-Hydroxycytidine

A nucleoside analogue that is cytidine which carries a hydroxy group at the N(4)-positon. It has broad-spectrum antiviral activity against influenza, SARS-CoV , SARS-CoV-2 and MERS-CoV. COVID info from DrugBank, Guide to PHARMACOLOGY Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

2-Chloro-N-phenethyl-benzamide

6-Fluoro-2-(2-methylphenyl)-1,2-benzothiazol-3-one

C14H10FNOS (259.0467102)

2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-5-(1H-pyrrol-2-yl)-

C12H10FN5O (259.08693420000003)

2-Fluoro-6-(3-methoxyanilino)purine

3-Amino-4-chloro-N-(2-cyanoethyl)benzenesulfonamide

C9H10ClN3O2S (259.01822300000003)

N-Sulfo-Alpha-D-Glucosamine

5-(1-naphthalenylamino)-3H-1,3,4-thiadiazole-2-thione

C12H9N3S2 (259.0237874)

2-[(2-Phenylethyl)thio]nicotinic acid

ML-099 (CID-888706) is a pan Ras-related GTPases activator that can activate Rac1, cell division cycle 42, Ras, Rab7, and Rab-2A[1].

Ethyl 2-(trifluoromethyl)imidazo[1,2-a]pyrimidine-3-carboxylate

C10H8F3N3O2 (259.0568584)

3-[(2,5-Dimethyl-furan-3-carbonyl)-amino]-benzoic acid

1-(2-Methoxyphenyl)-3-pyridin-2-ylthiourea

3-(3,4-Dimethylanilino)-1-thiophen-2-yl-1-propanone

C15H17NOS (259.1030792)

2-[(3,4-Dimethylphenyl)sulfanyl]pyridine-3-carboxylic acid

N-(7-chloro-4-quinazolinyl)-N-(2-furylmethyl)amine

2-[(4-Methoxyphenyl)sulfonyl-methylamino]acetic acid

(3R)-3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione

N-[[(6-methyl-4-pyrimidinyl)thio]methyl]benzamide

dimethyl 2-phenyl-1H-pyrrole-3,4-dicarboxylate

(3,4-Dihydroxy-2-nitrophenyl)(phenyl)methanone

D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D004791 - Enzyme Inhibitors > D065098 - Catechol O-Methyltransferase Inhibitors

3-(Oxalyl-amino)-naphthalene-2-carboxylic acid

O-Benzylsulfonyl-Serine

Sn-glycero-3-phosphoserine

A glycerol 1-phosphoserine in which the glycero portion has R-configuration.

Glucosamine 4-phosphate

1,1,1-Trifluoro-3-acetamido-4-phenyl butan-2-one(n-acetyl-l-phenylalanyl trifluoromethyl ketone)

Ethyl 4-nitrophenyl ethylphosphonate

p-Nitrophenyl-O-ethyl ethylphosphonate

D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors D004791 - Enzyme Inhibitors Same as: D01591

Tiletamine Hydrochloride

C12H18ClNOS (259.0797568)

D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D002491 - Central Nervous System Agents > D000927 - Anticonvulsants C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

BEMORADAN

C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor

Skimmianin

InChI=1\C14H13NO4\c1-16-10-5-4-8-11(13(10)18-3)15-14-9(6-7-19-14)12(8)17-2\h4-7H,1-3H

Kokusaginin

4-27-00-02295 (Beilstein Handbook Reference)

Tarac

4-amino-1-[3,4-dihydroxy-5-(hydroxymethyl)thiolan-2-yl]-1,2-dihydropyrimidin-2-one

C9H10NO6P-2 (259.02457300000003)

O(4)-phosphonato-L-tyrosine(2-)

Biotinate sulfoxide(1-)

C10H15N2O4S- (259.075249)

A monocarboxylic acid anion that is the conjugate base of biotin sulfoxide; major species at pH 7.3.

5-phospho-D-arabinonohydroxamate

C5H10NO9P-2 (259.009318)

alpha-D-glucosamine 6-sulfate

C9H10NO6P-2 (259.02457300000003)

5-Mercaptodeoxyuridine

C9H11N2O5S- (259.0388656)

3,6,8-Trihydroxy-9-oxoxanthen-4-olate

C13H7O6- (259.0242622)

4,6,8-Trihydroxy-9-oxoxanthen-1-olate

C13H7O6- (259.0242622)

3,6,7-Trihydroxy-9-oxoxanthen-1-olate

C13H7O6- (259.0242622)

O(4)-phosphonato-D-tyrosine(2-)

2-Amino-2-Deoxy-6-O-Sulfo-Alpha-D-Glucopyranose

C6H11O9S- (259.01237760000004)

[(2R,3S,4S,5R,6R)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl sulfate

Glucosamine 6-Phosphate (closed ring, complete stereochemistry)

[(2R,3R,4R,5R,6S)-5-amino-3,4,6-trihydroxyoxan-2-yl]methyl dihydrogen phosphate

Sec-butylmercury

C4H9Hg+ (259.0410534)

3-Amino-3-deoxy-beta-D-fructofuranose 6-phosphoric acid

1-Methyl-1,2,3,4-tetrahydroisoquinoline-6,7-diol hydrobromide

6,7-Isoquinolinediol,1,2,3,4-tetrahydro-1-methyl-, hydrobromide (1:1)

caerulomycin C